Brief: Personalis Announces New Publication Applying Ultrasensitive CtDNA Testing
17/12/2025 11:15
Dec 17 (Reuters) - Personalis Inc PSNL.O: PERSONALIS ANNOUNCES NEW PUBLICATION APPLYING ULTRASENSITIVE CTDNA TESTING TO MONITORING CANCER IMMUNOTHERAPY RESPONSE ACROSS SOLID TUMORS Source text: ID:nBw6kkFM4a Further company coverage: PSNL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary